FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implant, Intragastric For Morbid Obesity

PMA: P160001 · Supplement: S027 · Decision Jan 11, 2019
Classifications
1
FEI Numbers
12
Registration Numbers
12

Basic Information

Device Name
Implant, Intragastric For Morbid Obesity
Trade Name
Obalon Touch Dispenser
PMA Number
P160001
Supplement Number
S027
Device Class
FDA Class 3
Product Code
LTI
Generic Name
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
Approved
Decision Code
APPR
Decision Date
January 11, 2019
Date Received
October 15, 2018
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for software changes relating to battery voltage thresholds and Touch Dispenser screens.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LTI Implant, Intragastric For Morbid Obesity